Key terms
About XTLB
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest XTLB news
Mar 22
11:33am ET
Biotech Alert: Searches spiking for these stocks today
Mar 21
4:58pm ET
XTL Biopharmaceuticals Convenes Extraordinary General Meeting
Mar 20
11:27am ET
XTL Biopharmaceuticals Acquires The Social Proxy
Mar 20
10:18am ET
XTL Biopharmaceuticals to acquire web data company The Social Proxy
No recent news articles are available for XTLB
No recent press releases are available for XTLB
XTLB Financials
Key terms
Ad Feedback
XTLB Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
XTLB Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range